Get started
Radiopharm Theranostics LimitedRadiopharm Theranostics LimitedRadiopharm Theranostics Limited

Radiopharm Theranostics Limited

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

RADX chart


Full chart

RADX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪35.42 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−12.28 USD
Net income (FY)
‪−31.42 M‬ USD
Revenue (FY)
‪196.08 K‬ USD
Shares float
—
Beta (1Y)
5.37

About RADIOPHARM THERANOSTICS LIMITED


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Riccardo Canevari
Website
radiopharmtheranostics.com
Headquarters
Carlton
Founded
2021
FIGI
BBG01PT2ZTY8
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RADX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as RADX.